NCT05631431 - Evaluation of Efficacy and Safety of Curalin As Add-On Therapy in Adults With Type 2 Diabetes Mellitus | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

October 15, 2021

Primary Completion Date

May 15, 2023

Study Completion Date

June 30, 2023

Conditions

Type2 Diabetes

Interventions

DIETARY_SUPPLEMENT

Curalin

Curalin capsules, 2 capsules, 3 times a day after meals Placebo: matching placebo capsules, 2 capsules, 3 times a day after meals

Trial Locations (4)

RECRUITING

Soroka Medical Center, Beersheba

RECRUITING

Lin Medical Center, Haifa

RECRUITING

Herzelia Diebetes Center, Herzliya

RECRUITING

Ichilov Medical Center, Tel Aviv